CompaniesGritstone Oncology

Gritstone Oncology

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (8)
View all

Total Trials

8

As Lead Sponsor

7

As Collaborator

1

Total Enrollment

651

By Phase

PHASE2: 1PHASE1: 3PHASE1/PHASE2: 2

By Status

COMPLETED: 7WITHDRAWN: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
NCT03794128
NCT03639714
NCT03953235
NCT04776317
NCT05148962
NCT05435027
Hover over trial bars to see details

Recent Trials

NCT05456165Lead Sponsor
Study of an Individualized Vaccine Targeting Neoantigens in Combination With Immune Checkpoint Blockade for Patients With Colon Cancer
PHASE2Withdrawn
Started: May 19, 2022 · Completed: Sep 1, 2022
NCT05435027Lead Sponsor
Study of Self-Amplifying Messenger Ribonucleic Acid (samRNA) Vaccines Against COVID-19 in Healthy Adults and People Living With Human Immunodeficiency Virus (HIV)
PHASE1Completed
342 participants
Started: Feb 28, 2022 · Completed: Mar 6, 2024
NCT05158621Lead Sponsor
A Screening Study Targeting Tumor-specific Antigens
N/ACompleted
22 participants
Started: Dec 14, 2021 · Completed: Aug 15, 2022
NCT05148962Lead Sponsor
Study of GRT-R910 COVID-19 Boost Vaccine in Healthy Volunteers
PHASE1Completed
45 participants
Started: Sep 16, 2021 · Completed: May 26, 2023
NCT04776317Collaborator
Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults
PHASE1Completed
81 participants
Started: Mar 25, 2021 · Completed: Sep 15, 2023
View all 8 trials →
Funding History (20)
8-K
Apr 4, 2025
Filing
8-K
Feb 25, 2025
Filing
8-K
Feb 14, 2025
Filing
8-K
Jan 3, 2025
Filing
8-K
Dec 13, 2024
Filing
8-K
Nov 29, 2024
Filing
8-K
Nov 15, 2024
Filing
8-K
Oct 16, 2024
Filing
8-K
Oct 10, 2024
Filing
8-K
Oct 1, 2024
Filing